Jacob Beer
Overview
Explore the profile of Jacob Beer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Godwa G, Beer J
J Drugs Dermatol
. 2024 Nov;
23(11):e181-e182.
PMID: 39496118
Skin cancer most commonly affects fair-skinned individuals1; however, it can appear in individuals of all skin tones. Photoprotective behaviors such as applying sunscreen should be practiced by all individuals regardless...
2.
Burke O, Beer J, Elman S
J Drugs Dermatol
. 2024 Jul;
23(7):569-570.
PMID: 38954612
Mycosis fungoides palmaris et plantaris (MFPP) is a rare variant of mycosis fungoides (MF), a type of cutaneous T-cell lymphoma. MFPP primarily affects the palms and soles of the feet...
3.
Beer J, Hermak S, Noor O
J Clin Aesthet Dermatol
. 2024 May;
17(5 Suppl 2):S7-S10.
PMID: 38726208
No abstract available.
4.
Burke O, Labib A, Burke G, Beer J, Nichols A
J Drugs Dermatol
. 2024 May;
23(5):376-379.
PMID: 38709686
Merkel cell carcinoma (MCC) is a rare, highly aggressive cutaneous malignancy. Immunosuppression increases the risk of MCC and is associated with poor prognosis. Organ transplant recipients (OTR) have worse overall...
5.
Burke O, Surowiec L, Beer J, Reyes-Iglesias Y
J Drugs Dermatol
. 2023 Dec;
22(12):e25-e27.
PMID: 38051846
Checkpoint inhibitors (CPIs) are increasingly being used in the treatment of malignant melanoma. While showing promise in metastatic melanoma treatment, CPIs are associated with immune-related adverse events in various organ...
6.
Bourgeois J, Beer J, Choi S, Bitar C
J Drugs Dermatol
. 2023 Nov;
22(11):e21-e23.
PMID: 37943262
Across the board, common dermatologic conditions disproportionately affect patients of color. While the causes of these disparities have been tied to the environment, societal structure, access to care, health literacy,...
7.
Bourgeois J, Beer J, Jacob L, Henry M
J Drugs Dermatol
. 2023 Jul;
22(7):7253.
PMID: 37410031
Importance: Managing chronic conditions is an essential aspect of dermatologic care, especially regarding the resolution of inflammatory dermatologic disease and recovery of skin lesions. Short-term complications of healing include infection,...
8.
McCollam G, McDaniel K, Beer J, Torosian A, Bourgeois J, Yim R, et al.
J Drugs Dermatol
. 2023 May;
22(5):511-513.
PMID: 37133473
No abstract available.
9.
Choi S, Beer J, Bourgeois J, Hill I
J Drugs Dermatol
. 2023 Apr;
22(4):417-418.
PMID: 37026878
As we continue to work toward a more equitable future of medicine, it is necessary to recognize the needs distinct to pediatric dermatology to decrease health disparities that affect this...
10.
Choi S, Beer J, Charrow A
Int J Dermatol
. 2023 Mar;
62(5):681-684.
PMID: 36912708
Background: As the climate crisis grows, so does the global burden of displacement. Displacement, whether a direct or indirect consequence of natural disaster, can lead to dire health sequelae. Skin...